TruElastin Laboratories
NJ-based biotech firm, TruElastin, pioneers in producing natural elastin biomaterials and innovative medical devices since 2010.
Founded
2010NJ-based biotech firm, TruElastin, pioneers in producing natural elastin biomaterials and innovative medical devices since 2010.
Founded in 2010, TruElastin Laboratories is a New Jersey-based biotech company focused on harnessing the therapeutic potential of natural elastin. The company's core mission is to develop and produce innovative medical devices and biomaterials derived from elastin, a critical protein that provides elasticity and strength to tissues. TruElastin's pioneering platform technology enables the reliable production of natural elastin biomaterials, leading to their first groundbreaking device aimed at various medical applications.
TruElastin Laboratories has attracted notable investors and industry experts who recognize the transformative potential of their technology. The company has achieved significant milestones, including the development and patenting of their elastin production platform. Their work has had a profound impact on the medical field, offering new solutions for tissue repair and regeneration. Through their innovative approach, TruElastin continues to advance the capabilities of medical devices, improving patient outcomes and setting new standards in biotechnology.
Companies similar to TruElastin Laboratories include Elastrin Therapeutics, NeXtGen Biologics, Elutia and EternoGen.
TruElastin Laboratories was founded in 2010.
TruElastin Laboratories' headquarters is located in Chatham Borough, NJ, US.
TruElastin Laboratories' most recent funding round was for $1.3M (USD) in August 2022.
As of Aug 5, 2022, TruElastin Laboratories has disclosed funding of $1.5M (USD). Undisclosed round amounts are excluded.
TruElastin Laboratories has 3 employees as of Feb 5, 2024.
EternoGen
